Trans fatty acids: Foods and effects on health;Ácidos graxos trans: Alimentos e efeitos na saúde

Archivos Latinoamericanos de Nutricion

Volumn 56, Issue 1, 2006, Pages

  Vasconcelos Costa, André Gustavo ^a   Bressan, Josefina ^a   Sabarense, Céphora Maria ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Child development; Coronary disease; Food; Lipoproteins; Trans fatty acids

Indexed keywords

ANIMALIA; BOVIDAE;

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANS FATTY ACID;

BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; FAT INTAKE; FEMALE; HUMAN; ISOMERISM; METABOLISM; PREGNANCY; REVIEW; RISK FACTOR; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FATS; FEMALE; HUMANS; ISOMERISM; PREGNANCY; RISK FACTORS; TRANS FATTY ACIDS; WORLD HEALTH ORGANIZATION;

EID: 33749118433     PISSN: 00040622     EISSN: 00040622     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Lichtenstein AL. Dietary fat: a history. Nutr Rev 1999; 57: 11-4.
2. Ascheiro A, Willett W. Health effects of trans fatty acids. Am J Clin Nutr 1997; 66 Suppl: 1006S-10S.
3. a ed. São Paulo: Manole; 2002. p. 509-521.
4. Kohlmeier L, Simonsen N, van't Veer P, Strain JJ, Martin-Moreno JM, Margolin B, et al. Adipose tissue trans fatty acids and breast cancer in the EURIMIC Study. Cancer Epidemiol Biomarkers Prev 1997; 6: 705-10.
5. Semma M. Trans fatty acids: properties, benefits and risks. J Health Sci 2002; 48: 7-13.
6. Simopoulos AP. Trans fatty acids. En: Spiller GA, editor. Handbook of lipids in human nutrition. 1ra ed. Ed Boca Raton: CRC Press; 1996. p. 91-9.
7. Larqué E, Zamora S, Gil A. Dietary trans fatty acids in early life: a review. 2
8. Sanibal EAA, Mancini-Filho, J. Perfil de ácidos graxos trans de óleo e gordura hidrogenada de soja no processo de fritura. Ciênc Tecnol Aliment 2004; 24: 27-31.
9. American Society for Clinical Nutrition ASCN/AIN Task Force on Trans Fatty Acids. Position paper on trans fatty acids. Am J Clin Nutr 1996; 63: 663-70.
10. World Health Organization. Diet, nutrition and the prevention of chronic diseases. Geneva: 2003.
11. Chiara VL, Sichieri R, Carvalho TSF. Teores de ácidos graxos trans de alguns alimentos consumidos no Rio de Janeiro. Rev Nutr 2003; 16: 227-33.
12. Sabarense CM, Mancini-Filho J. Ácidos graxos trans e as lipoproteínas plasmáticas. J Brazillian Soc Food Nutr 2004; 27: 69-83.
13. Chiara VL, Silva R, Jorge R, Brasil AP. Ácidos graxos trans: doenças cardiovasculares e saúde materno-infantil. Rev Nutr 2002; 15: 341-49.
14. Block JM, Barrera-Arellano D. Produtos hidrogenados no Brasil: isômeros trans, características físico-químicas e composição em ácidos graxos. Arch Latinoam Nutr 1994; 44: 281-85.
15. Bayard CC, Wolff RL. Trans-18:1 acids in French tub margarines and shortenings: recent trends. JAOCS 1995; 72: 1485-89.
16. Velenzuela A, Morgado N. Trans fatty acid isomers in human health and in the food industry. Biol Res 1999; 32: 273-87.
17. Allison DB, Ergan SK, Barraj LM, Caughman C, Infante M, heimbach JT. Estimated intake of trans fatty acid and other fatty acids in the US population. J Am Diet Assoc 1999; 99: 166-74.
18. Ratnayake WMN, Pelletier G, Hollywood R, Bacler S, Leyte D. Trans fatty acids in Canadian maragarines: recent trenes. J Am Oil Chem Soc 1998; 75: 1587-94.
19. van Poppel G, van Erp-Baart MA, Leth T, Gevers E, Van Amelsvoort J, Lanzmann-Petithory D, et al. Trans fatty acids in foods in Europe: the TRANSFAIR Study. J Food Compos Anal 1998; 11: 112-36.
20. Aro A, Van Amelsvoort J, Becker W, van Erp-Baart MA, Kafatos A, Leth T, et al. Trans fatty acids in dietary fats and oils from 14 European countries: the TRANSFAIR Study. J Food Compos Anal 1998; 11: 137-49.
21. Hulshof KFAM, van Erp-Baart MA, Anttolainen M, Becker W, Church SM, Couet C, et al. Intake of fatty acids in Western Europe with emphasis on trans fatty acids: the TRANSFAIR Study. Eur J Clin Nutr 1999; 53: 143-57.
22. Lemaitre RN, King IB, Raghunathan TE, Pearce RM, Weinmann S, Knopp RH, et al. Cell Membrane trans-fatty acids and risk of primary cardiac arrest. Circulation 2001; 12: 697-701.
23. Scrimgeour CM, Macvean A, Fernie CE, Sébédio JL, Riemersma RA. Dietary trans a -linolenic acid does not inhibit D 5- and D 6-desaturation of linoléico acid in man. Eur J Lipid Sci Technol 2001; 103: 341-49.
24. Ross NM, Siebelink E, Bots ML, van Tol A, Schouten EG, Katan MB. Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flow-mediated vasodilation. Eur J Clin Nutr 2002; 56: 674-79.
25. Boué C, Combe N, Billeaud C, Mignerot C, Entressangles B, Thery G. Trans fatty acids in adipose tissue of French women in relation to their dietary sources. Lipids 2000; 35: 561-66.
26. Loï C, Chardigny JM, Almanza S, Leclere L, Ginies C, Sébédio JL. Incorporation and metabolism of dietary trans isomers of linolênico acid alter the fatty acid profile of rat tissues. J Nutr 2000; 130: 2550-55.
27. Sabarense CM, Mancini-Filho J. Efeito da gordura vegetal parcialmente hidrogenada sobre a incorporação de ácidos graxos trans em tecidos de ratos. Rev Nutr 2003; 16: 399-407.
28. Moore CE, Alfin-Slater RB, Aftergood L. Incorporation and disappearence of trans fatty acids in rat tissues. Am J Clin Nutr 1980; 33: 2318-23.
29. a revisão. São Paulo: Centro Brasileiro de Classificação de Doenças; 1985.
30. Schaefer EJ. Lipoprotein, nutrition, and health disease. Am J Cln Nutr 2002; 75: 191-212.
31. Roos NM, Siebelink E, Bots ML, van Tol A, Schouten EG, Katan MB. Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flown-mediated vasodilation. Eur J Clin Nutr 2002; 56 ( 7): 674-679.
32. Mann GV. Metabolic consequences of dietary trans fatty acids. Lancet 1994; 343: 1268-71.
33. Allison DB, Denke MA, Dietschy JM, Emken EA, Kris-Etherton PM, Nicolosi RJ. Trans fatty acids and coronary heart disease risk. Report of the expert panel on trans fatty acids and coronary heart disease. Am J Clin Nutr 1995; 62: 655-708.
34. van de Vijver LPL, Kardinaal AFM, Couet C, Aro A, Kafatos A, Steingrimsdottir L, et al. Association between trans fatty acid intake and cardiovascular risk factors in Europen: the TRANSFAIR Study. Eur J Clin Nutr 2000; 54: 126-135.
35. Aro A, Kardinaal AFM, Salminen I, Kark JD, Riemersma RA, Delgado-Rodriguez M, et al. Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC Study. Lancet 1995; 345: 273-78.
36. Armstrong RA, Chardigny JM, Beaufrère B, Bretillon L, Vermunt SHF, Mensink RP, et al. No effect of dietary trans isomers of a -linolenic acid on platelet aggregation and haemostatic factors in European healthy men: the TRANSLinE Study. Thromb Res 2000; 100: 133-41.
37. Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004; 79: 606-12.
38. Sales RL, Pelúzio MCG, Costa NMB. Lipoproteínas: uma revisão do seu metabolismo e envolvimento com o desenvolvimento de doenças cardiovasculares. J Brazillian Soc Food Nutr 2003; 25: 71-86.
39. Gatto LM, Lyons MA, Brown AJ, Samman S. Trans fatty acids affect lipoprotein metabolism in rats. J Nutr 2002; 132: 1242-48.
40. Guzmán M, Klein W, Pulgar TG, Geelen MJH. Metabolism of trans fatty acids by hepatocytes. Lipids 1999; 34: 381-86.
41. Lichtenstein AH, Jauhiainen M, McGladdery S, Ausman LM, Jalbert SM, Vilella-Bach M, et al. Impact of hydrogenated fat on high density lipoprotein subfractions and metabolism. J Lipid Res 2001; 42: 597-604.
42. Dashti N, Feng Q, Freeman MR, Gandhi M, Franklin FA. Trans polyunsatured fatty acids have more adverse effects than saturated fatty acids on the concentration and composition of lipoproteins secreted by human hepatoma HepG2 cells. J Nutr 2002; 132: 2651-59.
43. Katan MB, Zock PL, Mensink RP. Trans fatty acids and their effects on lipoproteins in humans. Ann Rev Nutr 1995; 15: 473-493.
44. Colandré ME, Diez RS, Bernal CA. Metabolic effects of trans fatty acids on an experimental dietary model. Br J Nutr 2003; 89: 631-38.
45. Larqué E, Zamora S, Gil A. Dietary trans fatty acids affect the essential fatty-acid concentration of rat milk. J Nutr 2000; 130: 847-51.
46. Assumpção RP, Santos FD, Andrade PMM, Barreto GF, Carmo MGT. Effect of variation of trans-fatty acid in lactating rats' diet on lipoprotein lípase activity in mammary gland, liver, and adipose tissue. Nutrition 2004; 20: 806-11.
47. Innis SM, King DJ. Trans fatty acids in human milk are inversely associated with concentrations or essential all-cis n-6 and n-3 fatty acids and determine trans, but not n-6 and n-3, fatty acids in plasma lipids of breast-fed infants. Am J Clin Nutr 1999; 70: 383-90.
48. Williams MA, King IB, Sorensen TK, Zingheim RW, Troyer BL, Zebelman AM. Risk of preeclampsia in relation to elaidic acids (trans fatty acid) in maternal erythrocytes. Gynecol Obstet Invest 1998; 46 (2): 84-87.
49. Elias SL, Innis SM. Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoléico acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr 2001; 73: 807-14.
50. Larqué E, Pérez-Llamas F, Puerta V, Girón MD, Suárez MD, Zamora S, et al. Dietary trans fatty acids affect docosahexaenoic acid concentrations in plasma and liver but not brain of pregnant and fetal rats. Pediatr Res 2000; 47: 278-83.